Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2022-07-25 00:00:00 ET · period of report 2022-07-22 · accession 0001567619-22-014431 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-25 | 2022-07-22 | RVMD | Kim Lorence H. | Dir | P - Purchase | $20.00 | +50.0K | 60.5K | +476% | +$1.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-22 | P | A | 50,000 | $20.00 | 60,500 | D | — | — | (F1) Includes 10,500 Restricted Stock Units. |